Cited by 627Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and TreatmentsCardiac electrophysiology and arrhythmias

The DOI matches its Crossref record.

Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia

Page, R L, Wilkinson, W E, Clair, W K, McCarthy, E A, Pritchett, E L·1994·Circulation

DOI 10.1161/01.cir.89.1.224

Open this paper in CoChat — free account

Abstract

BACKGROUND: Paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia are recognized clinically when patients seek treatment for symptoms due to recurrent arrhythmias; atrial fibrillation also increases the risk of stroke. The frequency with which asymptomatic arrhythmias occur in patients with these arrhythmias is unknown. METHODS AND RESULTS: Twenty-two patients with paroxysmal atrial fibrillation (n = 8) or paroxysmal supraventricular tachycardia (n = 14) were studied for 29 days with two different ambulatory ECG-monitoring techniques to measure the relative frequency of asymptomatic and symptomatic arrhythmias. All class I antiarrhythmic drugs, calcium channel blockers, beta-blockers, and digitalis were withheld. Sustained asymptomatic arrhythmia events (defined as lasting at least 30 seconds) were documented using continuous ambulatory ECG monitoring once weekly for a total of 5 of the 29 study days; symptomatic arrhythmia events were documented using transtelephonic ECG monitoring for all 29 days of the study. In the group of patients with paroxysmal atrial fibrillation, asymptomatic arrhythmia events occurred significantly more frequently than symptomatic arrhythmia events; the mean rates, expressed as events/100 d/patient (95% confidence interval), were 62.5 (40.4, 87.3) and 5.2 (2.7, 9.0) (P < .01); the ratio of the mean rates was 12.1 (5.8, 26.4). In contrast, in the group of patients with paroxysmal supraventricular tachycardia, asymptomatic arrhythmia events were significantly less frequent than symptomatic arrhythmia events; the mean rates were 0.0 (0.0, 5.3) and 7.4 (5.0, 10.6) (P = .02). The ratio of the mean rates was 0.0 (0.0, 0.8). CONCLUSIONS: In a group of patients with paroxysmal atrial fibrillation, sustained asymptomatic atrial fibrillation occurs far more frequently than symptomatic atrial fibrillation. However, it is not known whether asymptomatic atrial fibrillation is a potential risk factor for stroke even when patients are not having symptomatic arrhythmias.

Integrity signals

Registry

Crossref · 10.1161/01.cir.89.1.224

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 401–500 of 622

Atrial Fibrillation Monitoring
Hindricks, G., & Piorkowski, C. (2012) · Circulation · doi:10.1161/circulationaha.112.124735 · Cited by 7
Clinical Profiles, Efficacy of Antiarrhythmic Drug Therapy, and Cardiovascular Prognosis in Patients With First Detected Paroxysmal Atrial Fibrillation
Komatsu, T., Tachibana, H., Satoh, Y., Ozawa, M., Kunugita, F., & Nakamura, M. (2011) · International Heart Journal · doi:10.1536/ihj.52.32 · Cited by 6
Monitoring Atrial Fibrillation After Catheter Ablation.
Forleo, G. B., Casella, M., Russo, A. D., Moltrasio, M., Fassini, G., Tesauro, M., & Tondo, C. (2014) · PubMed Central · doi:10.4022/jafib.1040 · Cited by 6
Diagnostic tools for atrial tachyarrhythmias in implantable pacemakers: a review of technical options and pitfalls
de Voogt, W. G., & van Hemel, N. M. (2008) · Netherlands Heart Journal · doi:10.1007/bf03086146 · Cited by 6
Atrial Fibrillation Therapy:
Scheinman, M. M. (2003) · Pacing and Clinical Electrophysiology · doi:10.1046/j.1460-9592.2003.t01-1-00166.x · Cited by 6
Symptomatic arrhythmia recurrence as an outcome in clinical trials of antiarrhythmic drug therapy
Pritchett, E. L. C. (2004) · Heart Rhythm · doi:10.1016/j.hrthm.2004.04.005 · Cited by 6
Self-citation
A controlled study on the effect of verapamil on atrial tachycaarrhythmias in patients with brady-tachy syndrome implanted with a DDDR pacemaker
Boriani, G., Bertaglia, E., Carboni, A., et al. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.10.012 · Cited by 6
“Palpitations are the most frequent symptom reported by patients with atrial tachyarrhythmias but it is known that the relationship between patients symptoms and documented arrhythmias is not strict, since a significant proportion of atrial fibrillation episodes are asymptomatic [20] or palpitations may be reported eve…”
Background
Problems in Pharmacological Evaluation of Patients with Paroxysmal Atrial Fibrillation: Clinical Analysis of More Than 100 Consecutive Patients.
Iga, K., Izumi, C., Nakano, A., Sakanoue, Y., Miyamoto, T., Kitaguchi, S., Himura, Y., Gen, H., & Konishi, T. (1998) · Internal Medicine · doi:10.2169/internalmedicine.37.1005 · Cited by 6
Detection of atrial tachyarrhythmias in an implantable monitoring device
Abe, H. (2012) · Journal of Arrhythmia · doi:10.1016/j.joa.2012.02.004 · Cited by 5
Understanding Atrial Fibrillation: The Signal Processing Contribution, Part I
Mainardi, L. T., Sörnmo, L., & Cerutti, S. (2008) · Synthesis lectures on biomedical engineering · doi:10.2200/s00152ed1v01y200809bme024 · Cited by 5
ANMCO-SIMEU consensus document: appropriate management of atrial fibrillation in the emergency department
Caldarola, P., Iaco, F. D., Pugliese, F. R., Luca, L. D., Fabbri, A., Riccio, C., Scicchitano, P., Vanni, S., Pasquale, G. D., Gulizia, M. M., et al. (2023) · European Heart Journal Supplements · doi:10.1093/eurheartjsupp/suad110 · Cited by 5
“the occurrence of AF; and (3) To estimate the thrombotic and hemorrhagic risks of the patient in order to manage the correct antithrombotic strategy.(61) Patient with unstable AF is defined in case of chest pain, pulmonary edema, persistent hypotension, shock, and altered state of consciousness.”
Background
Slow Sinus Heart Rate as a Potential Predictive Factor of Paroxysmal Atrial Fibrillation in Stroke Patients
Hoshino, T., Ishizuka, K., Nagao, T., et al. (2013) · Cerebrovascular Diseases · doi:10.1159/000353184 · Cited by 5
Atrial Fibrillation and Stroke: The Evolving Role of Rhythm Control
Patel, T. K., & PASSMAN, R. S. (2013) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-013-0234-9 · Cited by 5
“Given the fact that most AF is asymptomatic and that intermittent monitoring alone is inadequate in assessing AF burden, the estimates of AF control in the major trials of rate vs rhythm control likely represent a vast overestimate of the efficacy of AAD therapy [12].”
Background
Validation of success following atrial fibrillation ablation: a European survey
Halimi, F., & ERVEN, L. V. (2009) · EP Europace · doi:10.1093/europace/eup128 · Cited by 5
Time–Frequency Analysis of Atrial Fibrillation
Sandberg, F., Stridh, M., & Sörnmo, L. (2008) · Synthesis lectures on biomedical engineering · doi:10.1007/978-3-031-01633-2_4 · Cited by 5
Long-term rhythm monitoring with an implantable loop recorder in patients after the first clinical atrial fibrillation episode. Towards an individualized management
Papakonstantinou, P. Ε., & SIMANTIRAKIS, E. N. (2019) · Minerva Cardioangiologica · doi:10.23736/s0026-4725.19.04883-7 · Cited by 5
Low Utility of Short-Term Rhythm Assessment Before Long-Term Rhythm Monitoring in Patients With Cryptogenic Stroke
Apple, S. J., Flomenbaum, D. E., Parker, M., Chhikara, S., Stolarov, A., Moser, J., Mathai, S. V., Seo, J., Ferrick, N. J., Chudow, J., et al. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.06.040 · Cited by 5
The Year in Clinical Cardiac Electrophysiology
Scheinman, M. M., & Keung, E. C. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.03.008 · Cited by 4
Rhythm Association and the Heart Rhythm Society Developed in Collaboration With the European Heart Atrial Fibrillation): Committee to Revise the 2001 Guidelines for the Management of Patients With the European Society of Cardiology Committee for Practice Guidelines (Writing Cardiology/American Heart Association Task Force on Practice Guidelines and Fibrillation—Executive Summary: A Report of the American College of ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial
Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, L., Despres, C., Dickstein, K., Lekakis, J. P., McGregor, K., Metra, M., Budaj, A., et al. (2006) · Cited by 5
Self-citation
Occurrence and Characteristics of Stroke Events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) Study
Sherman, D. G., Kim, S. G., & Boop, B. S. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.08.247 · Cited by 5
“It is well known that for every symptomatic episode of AF, there are many that are asymptomatic.(21) Perhaps patients taking antiarrhythmic therapy are more likely to be asymptomatic with bouts of AF.”
Background
Cardiac Monitoring for Atrial Fibrillation in Cryptogenic Stroke
Ringwala, S. M., Tomson, T. T., & PASSMAN, R. S. (2016) · Cardiology Clinics · doi:10.1016/j.ccl.2015.12.010 · Cited by 5
Catheter ablation of atrial fibrillation: A treatment frontier
DOMANSKI, M. J., & Waldo, A. L. (2006) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-006-9024-6 · Cited by 5
“This is of particular concern because of the known high rate of asymptomatic recurrence of atrial fibrillation in the face of antiarrhythmic drug therapy [10, 13, 20].”
Background
Three Generation β-Blockers for Atrial Fibrillation Treatment
Francisco, A. C., Awata, W. M. C., Rufino, T. L. S., Potje, S. R., Prohaska, C. C., Ceron, C. S., & do Vale, G. T. (2022) · Current Hypertension Reviews · doi:10.2174/1573402118666220609161044 · Cited by 4
The Use of Transtelephonic Loop Recorders for the Assessment of Symptoms and Arrhythmia Recurrence After Radiofrequency Catheter Ablation
Vassilikos, V. P., Vogas, V., Giannakoulas, G. A., Mantziari, L., Lekka, I., Dimitrakopoulos, K., Paraskevaidis, S., Konias, S., Maglaveras, N., Chouvarda, I., et al. (2010) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2010.0018 · Cited by 4
“13 The authors showed that in the group of patients with paroxysmal atrial fibrillation, asymptomatic events occurred more frequently than symptomatic, whereas paroxysmal supraventricular tachycardia was more often symptomatic.”
Relationship Between the Long-Term Preventive Effect of Combined Treatment With Antiarrhythmic Drugs Plus Angiotensin-Converting Enzyme Inhibitors and Circadian Variation in the Onset of Paroxysmal Atrial Fibrillation
Komatsu, T., Tachibana, H., Satoh, Y., Ozawa, M., Kunugida, F., & Nakamura, M. (2010) · International Heart Journal · doi:10.1536/ihj.51.331 · Cited by 4
Prospective Comparative Study of Intravenous Cibenzoline and Disopyramide Therapy in the Treatment of Paroxysmal Atrial Fibrillation After Cardiovascular Surgery
Komatsu, T., Tachibana, H., Satoh, Y., Ozawa, M., Kunugita, F., Tashiro, A., Okabayashi, H., & Nakamura, M. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0023 · Cited by 4
Atrial fibrillation variability on long‐term monitoring of implantable cardiac rhythm management devices
Kaplan, R. M., Ziegler, P., Koehler, J. L., Glotzer, T. V., & PASSMAN, R. S. (2017) · Clinical Cardiology · doi:10.1002/clc.22766 · Cited by 4
The Prevalence of Sinus Rhythm in Patients with “Permanent” Atrial Fibrillation
Ziegler, P., Sakaguchi, S., Simons, G. R., Koehler, J. L., & Warman, E. N. (2014) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12354 · Cited by 4
Supraventricular Dysrhythmias
Funk, M., Wood, K., Valderrama, A. L., & Dunbar, S. B. (2007) · The Journal of Cardiovascular Nursing · doi:10.1097/01.jcn.0000267828.57944.07 · Cited by 3
“Goldner et al, 1998* & Prospective, descriptive 33 patients sedated by anesthesiologist; 26 patients sedated by electrophysiologist certified in use of conscious sedation Pain with external cardioversionTo compare the safety, efficacy, and cost of conscious sedation administered by an electrophysiologist versus anesth…”
BackgroundInfluential
Managing newly diagnosed atrial fibrillation: Rate, rhythm, and risk
Callahan, T. D., & Baranowski, B. (2011) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.78a.09165 · Cited by 4
Exploring the Potential Role of Catheter Ablation in Patients with Asymptomatic Atrial Fibrillation: Should We Move away from Symptom Relief?
Forleo, G. B., Biase, L. D., Rocca, D. G. D., Fassini, G. M., Santini, L., Natale, A., & Tondo, C. (2013) · Europe PMC (PubMed Central) · doi:10.4022/jafib.961 · Cited by 4
Is it safe to stop oral anticoagulation after catheter ablation for atrial fibrillation?
Romero, J. E., Avendaño, R., Díaz, J. C., Taveras, J. M., Lupercio, F. A., & Biase, L. D. (2018) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2019.1550718 · Cited by 4
“favor of continuingOAC after ablation [47].”
NHG-Standaard Atriumfibrilleren
Boode, B. S. P., Heeringa, J., Konings, K., Rutten, F., den Berg, P. V., Zwietering, P. J., van Lieshout, J., & Opstelten, W. (2011) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-8279-8_18 · Cited by 4
Immediate and Long-term Prevention of Thromboembolism in Atrial Fibrillation (AF)
Blackshear, J. L., & Safford, R. E. (1999) · Cardiac Electrophysiology Review · doi:10.1023/a:1009949007486 · Cited by 4
Clinical associations and prognosis in Asian and European patients with symptom‐controlled atrial fibrillation: Insights from two prospective registries in Europe and Asia
Teo, W. S., Zhao, M., Bucci, T., Lam, S. H. M., Liu, H., Chen, Y., Boriani, G., Tse, H., Chao, T., & Lip, G. Y. H. (2025) · European Journal of Clinical Investigation · doi:10.1111/eci.70086 · Cited by 3
The Temporal Relationship Between Atrial Fibrillation and Ischemic Stroke.
Ziegler, P. (2013) · Europe PMC (PubMed Central) · doi:10.4022/jafib.738 · Cited by 3
The Year in Clinical Cardiac Electrophysiology
Marcus, G. M., Scheinman, M. M., & Keung, E. C. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.017 · Cited by 3
Atrial fibrillation: focus on monitoring strategies after cryptogenic stroke
BUONO, M. G. D., & SANNA, T. (2022) · Minerva Cardiology and Angiology · doi:10.23736/s2724-5683.21.05851-8 · Cited by 3
MR-proANP measured at admission is associated with incident atrial fibrillation in STEMI patients
Wegener, A., Modin, D., Pedersen, S. H., Lindberg, S. Ø., Pareek, M., Iversen, K. K., Jespersen, T., Gislason, G., & Biering‐Sørensen, T. (2022) · Heart and Vessels · doi:10.1007/s00380-022-02099-8 · Cited by 3
“AF is frequently asymptomatic [29], making early detection of AF important for reducing morbidity and mortality.”
Background
New atrial arrhythmia occurrence in single chamber implantable cardioverter defibrillator patients: A real‐world investigation
Patel, D. R., Rao, A., Friedman, P. A., Deshmukh, A. J., Lande, J. D., Murphy, J. A., Brown, M. L., Lexcen, D. R., & Wilkoff, B. L. (2022) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.15790 · Cited by 3
Challenging anticoagulation decisions in atrial fibrillation: a narrative review
Griffin, M., Proietti, R., Lip, G. Y. H., & Abdul‐Rahim, A. H. (2024) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/17539447241290429 · Cited by 3
Efficacy of Long‐term Flecainide Therapy in Patients with Paroxysmal Atrial Fibrillation —Analysis Based on Time of Onset—
Komatsu, T., Satou, Y., Tachibana, H., et al. (2006) · Journal of Arrhythmia · doi:10.1016/s1880-4276(06)80005-0 · Cited by 3
Epidemiological study on atrial fibrillation among aged members of a Japanese community
Imanaka, S. (2008) · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics · doi:10.3143/geriatrics.45.634 · Cited by 3
Does Atrial Fibrillation Detected by Cardiac Implantable Electronic Devices Have Clinical Relevance?
Glotzer, T. V., & Ziegler, P. (2014) · Cardiology Clinics · doi:10.1016/j.ccl.2013.11.001 · Cited by 3
Innovative pacing: Recent advances, emerging technologies, and future directions in cardiac pacing
Austin, C. O., & Kusumoto, F. M. (2016) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2016.02.006 · Cited by 3
Rate Control in Atrial Fibrillation: Methods for Assessment, Targets for Ventricular Rate during AF, and Clinical Relevance for Device Therapy.
Sarkar, S., & Ziegler, P. (2013) · Europe PMC (PubMed Central) · doi:10.4022/jafib.791 · Cited by 3
EKG-Telemonitoring
Oeff, M., Müller, A., Neuzner, J., Sack, S., SCHWAB, J. O., Pfeiffer, D., & Zugck, C. (2008) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-008-0012-7 · Cited by 3
Appropriateness of ECG Holter requests in an outpatient service: a prospective study
Piccirilli, S., Gallagher, M. M., Vellini, M., Padula, M., Voumvourakis, A., Santini, L., Magliano, G., & Romeo, F. (2007) · Journal of Cardiovascular Medicine · doi:10.2459/01.jcm.0000278449.96988.82 · Cited by 3
Pharmacotherapy of Atrial Fibrillation
Kasliwal, R. R., Mukesh, S., Manohar, G., Aggarwal, N., & Bhatia, A. (2003) · Asian Cardiovascular and Thoracic Annals · doi:10.1177/021849230301100424 · Cited by 3
Endpunkte für Studien bei Patienten mit Vorhofflimmern
Kirchhof, P. F., Goette, A., Hindricks, G., Hohnloser, S., Kück, K., Meinertz, T., Ravens, U., Steinbeck, G., & Breithardt, G. (2007) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-007-0581-x · Cited by 3
Antithrombotic Treatment after Atrial Fibrillation Ablation
Antoniou, C. K., Manolakou, P., Αρσένος, Π., Dilaveris, P., Gatzoulis, K. A., & Tousoulis, D. M. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200407154329 · Cited by 3
Monitoring of Atrial Tachyarrhythmias
Mehra, R. (2002) · Cardiac Electrophysiology Review · doi:10.1023/a:1016372823942 · Cited by 3
“This technique has limitations due to clustering of atrial tachyarrhythmias [11] and because many episodes tend to be asymptomatic [20].”
Heart Rate During Spontaneous and Induced Paroxysmal Supraventricular Tachycardia
Hamer, M. E., Wilkinson, W. E., McCarthy, E. A., et al. (1995) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1995.tb04641.x · Cited by 3
Self-citation
Optimal Management of the Patient with an Episode of Atrial Fibrillation In and Out of the Hospital
Knight, B. P., & Morady, F. (1999) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1999.tb00696.x · Cited by 3
When will we know enough to treat atrial fibrillation?
Anderson, M. E. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.02.015 · Cited by 3
Effect of Atrial Tachyarrhythmia Duration on Percentage of Time with Atrial Pacing in Pacemaker Patients with Paroxysmal Atrial Fibrillation
Schuchert, A., Frost, G., & Meinertz, T. (2004) · Journal of Interventional Cardiac Electrophysiology · doi:10.1023/b:jice.0000042353.87671.1d · Cited by 3
“Several studies, in whom Holter-ECG and event-recording systems were used in patients with atrial fibrillation, demonstrated that most episodes of paroxysmal atrial fibrillation remain asymptomatic or silent for the patient [16,17].”
Result
Influence of structural heart disease on characteristics of atrial fibrillation recurrence in patients with dual-chamber pacemakers
Reiter, M. J., Harsch, M. R., Lung, T., Munneke, D., Kim, M. H., & Shalaby, A. A. (2008) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2008.09.002 · Cited by 3
Lessons Learnt from Multisite Pacing for AF Management—Technical Challenges
Mehra, R., Kaemmerer, B., & Fitts, S. M. (2000) · Journal of Interventional Cardiac Electrophysiology · doi:10.1023/a:1009826414487 · Cited by 3
Managing atrial fibrillation — redrawing a line in the sand
Kilborn, M. J. (2003) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2003.tb05319.x · Cited by 3
Prevention of Thromboembolism in Patients with New Onset or Recently Discovered Atrial Fibrillation
Blackshear, J. L. (1997) · Cardiac Electrophysiology Review · doi:10.1023/a:1009951132125 · Cited by 3
Increased Body Mass Index is Associated with Device Detected Silent Atrial Fibrillation
Bozbeyoğlu, E., & Çinier, G. (2018) · Koşuyolu Heart Journal · doi:10.5578/khj.67510 · Cited by 2
Epicardial and endocardial surgical ablation of atrial fibrillation: outcomes from CASE-AF Registry
Mitrovic, I., Eszlári, E., Cvorak, A., Liebold, A., Rastan, A. J., Grubitzsch, H., Knaut, M., Fischlein, T. J. M., Ouarrak, T., Senges, J., et al. (2024) · Interdisciplinary CardioVascular and Thoracic Surgery · doi:10.1093/icvts/ivae123 · Cited by 2
“It was found that asymptomatic AF occurred 12 times more frequently than symptomatic AF when Holter monitoring was used for follow-up [12].”
Background
Silent atrial fibrillation: A clinical conundrum
Turagam, M. K. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.03.165 · Cited by 2
“The term “silent AF” is complicated as most patients with paroxysmal AF never report clinical symptoms, especially during the earlier stages [3].”
Background
Temperament, stress, and atrial fibrillation
Maryniak, A., Hasiec, A., Duda, B., Orczykowski, M., & Szumowski, Ł. J. (2015) · Polish Psychological Bulletin · doi:10.1515/ppb-2015-0030 · Cited by 2
“This may have distorted the results because some AF episodes are not detected by patients (Saveliev & Camm, 2000; Page et al., 1994).”
Where there is smoke, there is fire: afib in SCD
Uniat, J., & Wood, J. C. (2024) · Blood Advances · doi:10.1182/bloodadvances.2024014119 · Cited by 2
Evaluation of the Patient with Palpitations and Non-life-threatening Cardiac Arrhythmias
Spratt, K. A., & Michelson, E. L. (2001) · doi:10.1007/978-1-4615-6601-4_8 · Cited by 2
Prise en charge de l’accident ischémique cérébral du sujet jeune en urgence : aspects étiologiques et thérapeutiquesEmergency care in young patients with acute stroke.
GOUPIL, A., Bourghol, B., Derouet, N., et al. (2002) · Réanimation · doi:10.1016/s1624-0693(02)00286-4 · Cited by 2
Detection of Atrial Fibrillation After Cryptogenic Stroke
Bernstein, R. A. (2012) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-012-0180-y · Cited by 2
“This technology is so sensitive that it allows the detection of rare, very brief, asymptomatic episodes of AF that likely would have eluded detection using standard in-patient telemetry or Holter monitoring [9].”
Background
When is Device-Detected Atrial Fibrillation Actionable?
Wasserlauf, J., & PASSMAN, R. S. (2018) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2017.11.007 · Cited by 3
What we have learned from the European Heart Rhythm Association consensus document on device-detected subclinical atrial tachyarrhythmias
Özcan, E. E. (2018) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2017.8223 · Cited by 2
“Many patients with ATs have no symptoms during episodes, and subclinical atrial fibrillation (SCAF) is 12-fold more frequent than symptomatic AF in patients with paroxysmal AF (1).”
Background
Therapie von Vorhofflimmern
Kirchhof, P. F., & BREITHARDT, G. E. (2007) · Der Internist · doi:10.1007/s00108-007-1899-5 · Cited by 2
Recognition of Supraventricular Arrhythmias in Holter ECG Recordings by ECHOView Color Map: A Case Series Study
Naydenov, S., Jekova, I. I., & Krasteva, V. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10090360 · Cited by 2
Time to First Recurrence as a Trial Endpoint: Time to Change?
Mehra, R. (2003) · Cardiac Electrophysiology Review · doi:10.1023/b:cepr.0000012396.77522.6e · Cited by 2
Pacing mode selection in patients with sick sinus syndrome.
Nielsen, J. C. (2007) · PubMed · Cited by 2
Asymptomatisches Vorhofflimmern bei systematischem Screening mittels Tele-EKG
Patten, M. (2005) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-005-0475-8 · Cited by 3
Optimal Management of the Patient with Chronic Atrial Fibrillation
Miller, J. M., Jayachandran, J. V., Coppess, M. A., & OLGIN, J. E. (1999) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1999.tb00698.x · Cited by 2
Guidelines for Anticoagulation of Atrial Fibrillation: Is It Time for an Update?
Waldo, A. L. (2006) · Springer eBooks · doi:10.1007/88-470-0371-7_23 · Cited by 2
“It is probable that these data are in part explained by a significant incidence of so-called silent or asymptomatic atrial fibrillation [19–22].”
Background
Asymptomatic Atrial Fibrillation
Page, R. L., Reiffel, J. A., & Tavel, M. E. (2001) · CHEST Journal · doi:10.1378/chest.119.2.628 · Cited by 2
Self-citation
Atrial fibrillation: When is rate control enough?
Saad, E., & Schweikert, R. A. (2004) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.71.9.713 · Cited by 2
Maintaining stability of sinus rhythm in atrial fibrillation: Antiarrhythmic drugs versus ablation
Naccarelli, G. V., Hynes, J. K., Wolbrette, D. L., Bhatta, L., Khan, M. R., & Luck, J. C. (2002) · Current Cardiology Reports · doi:10.1007/s11886-002-0042-4 · Cited by 2
Self-limited bursts of atrial fibrillation following successful cardioversion
Nergårdh, A., Rosenqvist, M., & Frick, M. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.08.007 · Cited by 2
4. Atrial fibrillation
Kilborn, M. J. (1999) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1999.tb127854.x · Cited by 2
Multisite Pacing for AF Management—Technical and Clinical Challenges
Mehra, R., Kaemmerer, B., & Fitts, S. M. (2000) · Cited by 2
Efficacy of Long-term Flecainide Therapy in Patients with Paroxysmal Atrial Fibrillation-Analysis Based on Time of Onset-
Komatsu, T., Satou, Y., Tachibana, H., et al. (2006) · Journal of Arrhythmia · doi:10.4020/jhrs.22.37 · Cited by 2
Monitoring Long-term Cardiac Activity with Contactless Radio Frequency SignalsPreprint
Chen, Y., Zhang, B.-B., Zhang, D., Li, Y., Lu, Z. P., Chen, J., Wang, H., Zhou, F., Pu, Y., Hu, Y., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4456442/v1 · Cited by 2
Data mining analysis of the influences of electrocardiogram P-wave morphology parameters on atrial fibrillation
Ouyang, C., Chen, Y. J., Tsai, J., Chang, Y.-J., Huang, T.-H., Hwang, K., Ho, Y.-C., & Ho, W. (2021) · Journal of Intelligent & Fuzzy Systems · doi:10.3233/jifs-189612 · Cited by 1
“Therefore, most patients are unaware that they have AF and fail to receive treatment early, which results in incurable permanent AF [5].”
Comparative Outcomes of Deep Sedation Versus General Anesthesia in Cryoablation for Atrial Fibrillation: Insights From the Korean Heart Rhythm Society Cryoablation Registry
Lee, J. S., Cha, M., Kwon, C. H., Cho, M. S., Nam, G., Oh, I., Lee, S., Kim, J. Y., Lee, S. H., Park, J., et al. (2026) · Korean Circulation Journal · doi:10.4070/kcj.2025.0352 · Cited by 1
“Furthermore, since AF recurrences are often asymptomatic, 29) there is a possibility of under-detection, particularly among patients with paroxysmal AF.”
Therapeutisches Management des nichtvalvulären Vorhofflimmerns
Bode, K., Sommer, P., Bollmann, A., & Hindricks, G. (2013) · Herz · doi:10.1007/s00059-013-3940-x · Cited by 1
Thromboembolic Risk Management in Paroxysmal Atrial Fibrillation after Brain Haemorrhage
Sanna, T., & Lazzaro, V. D. (2011) · International Journal of Stroke · doi:10.1111/j.1747-4949.2010.00548.x · Cited by 1
Atrial fibrillation (mechanistic view point)
Henein, M., Henein, M., Calcuttea, A., et al. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.12.063 · Cited by 1
Detection of Asymptomatic Paroxysmal Atrial Fibrillation with the Trans-Telephonic Electrocardiograph System
Wu, C.-F., Yang, C.-Y., Li, A.-H. A., et al. (2012) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2011.0121 · Cited by 1
“7 Considering the fact that most AF episodes are asymptomatic, 5,6 methods to effectively and expeditiously detect and prevent PAF should be one of the crucial issues to PAF.”
Metabolic Syndrome as a Risk Factor for Atrial Fibrillation in Patients with Acute Myocardial Infarction
Shin, W. S., Park, M. Y., Hwang, Y. M., Jeon, H. K., Lee, M. Y., Lee, J. M., Shim, B. J., Kim, S. S., Lee, S. J., Oh, Y., et al. (2011) · The Korean Journal of Critical Care Medicine · doi:10.4266/kjccm.2011.26.1.6 · Cited by 1
Is There a Role for Bi-Atrial Pacing Resynchronisation Therapy in the Management of Drug-Refractory Atrial Fibrillation in Patients Unsuitable for Left Atrial Ablation?
Sankaranarayanan, R., James, M. A., Gonna, H., Burtchaell, S., Holloway, R., & Ewings, P. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0571 · Cited by 1
Comparison of the effects of bepridil and aprindine for the prevention of atrial fibrillation after cardiac and aortic surgery: A prospective randomized study
Ozawa, M., Komatsu, T., Satō, Y., Kunugita, F., Tachibana, H., Tashiro, A., Okabayashi, H., & Nakamura, M. (2015) · Journal of Arrhythmia · doi:10.1016/j.joa.2015.04.003 · Cited by 1
“We may have overlooked asymptomatic AF [40] because we did not perform continuous electrocardiographic monitoring in all cases for 2 weeks postoperatively.”
Method
To Shock or Not to Shock: That is the Question; is There an Answer?
Sachs, C. J., & Schriger, D. L. (2010) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2010.11.001 · Cited by 1
Management des Vorhofflimmerns
Hilbert, S., Bode, K., John, S., Kircher, S., Müssigbrodt, A., Dagres, N., & Hindricks, G. (2014) · Der Kardiologe · doi:10.1007/s12181-014-0613-9 · Cited by 1
Symptoms of Atrial Fibrillation
Dadkhah, S., & Sharain, K. (2016) · Contemporary cardiology · doi:10.1007/978-3-319-31386-3_5 · Cited by 1
Evaluating the benefits of home-based management of atrial fibrillation: current perspectives
Sheikh, A. B., Felzer, J., Munir, A., Morin, D. P., & Lavie, C. J. (2016) · Pragmatic and Observational Research · doi:10.2147/por.s96670 · Cited by 2
“…abnormalities, and increased interval of sinus node recovery 38 ; 3) elevated levels of inflammatory markers such as C-reactive protein 39 and interleukin-6 40 ; 4) higher levels of serum amyloid 41 ; and 5) enhanced vagal activation via negative tracheal pressure during obstructive events.”
Chronic Atrial Fibrillation
Lardizabal, J. A., & Sharma, S. (2013) · Journal of Hypertension and Cardiology · doi:10.14302/issn.2329-9487.jhc-12-edt1 · Cited by 1
Non-interventional Management of Symptomatic Pulmonary Vein Occlusion after Radiofrequency Ablation for Atrial Fibrillation.
Bittinger, L., & TANG, A. S. L. (2012) · Europe PMC (PubMed Central) · doi:10.4022/jafib.364 · Cited by 1

Authors: Page, R. L., Wilkinson, W. E., Clair, W. K., McCarthy, E. A., & Pritchett, E. L.
Affiliations: Duke Medical Center (US)
ORCID: Page, R L
Wilkinson, W E
Clair, W K
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1994-01
Volume: 89
Issue: 1
Pages: 224-227
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.89.1.224
OpenAlex: W2010550566
Cited by: 627
References: 0
Citations by year: 2026: 3 · 2025: 5 · 2024: 12 · 2023: 15 · 2022: 16 · 2021: 19 · 2020: 11 · 2019: 9 · 2018: 20 · 2017: 19 · 2016: 21 · 2015: 25 · 2014: 29 · 2013: 25 · 2012: 31
FWCI: 7.88
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (1r01hl040392-01a1)
National Heart, Lung, and Blood Institute (R01-HL-40392)
National Center for Research Resources (MO 1 RR-30)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords: paroxysmal atrial fibrillation, paroxysmal supraventricular tachycardia, asymptomatic arrhythmia, arrhythmia frequency, Holter monitoring, stroke risk, antiarrhythmic drugs, calcium channel blockers, beta-blockers
MeSH terms: Atrial Fibrillation, Female, Humans, Male, Middle Aged, Stochastic Processes, Tachycardia, Paroxysmal, Tachycardia, Supraventricular, Time Factors, Electrocardiography, Ambulatory, Confidence Intervals

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks